Submitted by Anonymous (not verified) on 4 August 2026 - 15:26
Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously Vyxeos), daunorubicin,cytarabine, Date of authorisation: 23/08/2018, Revision: 11, Status: Authorised
Source: